• Private Equity Firm

    Shavit Capital is an investment firm that specializes in late-stage investments in Israeli and Israeli-related companies.

    Shavit Capital has over $400 million under management across five separate private equity funds. Shavit Capital was founded in 2008 and the fifth fund was raised in 2018.  The Funds invest in Israeli companies with proven technologies, products, markets and strong management teams. The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise relatively larger amounts pursuant to an IPO on a major international public exchange or a dual listing of a company that trades on the Tel Aviv Stock Exchange.

    Shavit Capital also invests in other late-stage opportunities, especially through PIPEs (Private Investment in Public Equites) of Israeli publicly-traded companies.

  • Company News

    Copaxone rival Mapi Pharma to build Jerusalem plant
    March 19, 2019
    Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocyclin
    March 7, 2019
    Foamix Announces Positive Results from Phase 3 Open-Label Safety Study Evalua
    February 27, 2019
    Gamida Cell Announces Immune Reconstitution Data from Completed Phase 1/2 Cli
    February 23, 2019
    Anchiano Therapeutics Announces Pricing of USD 30.5 Million Initial Public Of
    February 12, 2019
    Anchiano Therapeutics files for USD 40m Nasdaq IPO
    January 8, 2019
    Alpha radiation startup eliminates 70% of cancerous tumors
    January 3, 2019
    Cannabis smart inhaler co Syqe Medical raises $50m
    December 31, 2018
    Anchiano Therapeutics Announces Initiation of Its Pivotal Codex Study of Inod
    December 18, 2018
    Anti-tumor DaRT could point the way to new arsenal in battle against cancer
    December 12, 2018